Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rexam Healthcare has announced the expansion of its La Verpillière site in Isère, France, to add a new building for the production of sub-sets of insulin injection pens, which are supplied to Eli Lilly and Company.
Subscribe to our email newsletter
New building will house 2400m² clean rooms devoted to produce the sub-sets of insulin injection pens.
Rexam has been supplying the sub-sets of insulin injection pen to Lilly since 2008 for which the site was first extended with plans to double the size by 2013.
The project represents around €15m investment over a period of three years.
Rexam leverages injection presses, marking machines, assembly line with ultrasound welding and packaging technology for the production and monitors each phase using camera system.
La Verpillière site that houses Rexam Healthcare’s European Technology Centre is specialized in drug administration systems including inhalers for asthma and injection devices.
The insulin injection pen is made of a twelve plastic parts and a metal spring and has two sub-sets including the dose selection mechanism, and the protective cap.
Eli Lilly Fegersheim site near Strasbourg produces the insulin filled glass cartridge that is inserted in the pen in addition to assembling sub-sets and insulin cartridge.
Image: Rexam Healthcare to extend La Verpillière site to manufacture sub-sets of Eli Lilly insulin injection pens.